These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27671071)

  • 1. Decreased Susceptibility to Tigecycline Mediated by a Mutation in mlaA in Escherichia coli Strains.
    He F; Xu J; Wang J; Chen Q; Hua X; Fu Y; Yu Y
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7530-7531. PubMed ID: 27671071
    [No Abstract]   [Full Text] [Related]  

  • 2. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.
    Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA
    J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.
    Linkevicius M; Sandegren L; Andersson DI
    J Antimicrob Chemother; 2013 Dec; 68(12):2809-19. PubMed ID: 23843301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Escherichia coli and Staphylococcus aureus isolates from a district general hospital in the U.K. to tigecycline and other antimicrobials.
    Chiriseri E; Minassian MA; Jenkins RO
    Br J Biomed Sci; 2010; 67(3):147-8. PubMed ID: 20973411
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamases.
    Vázquez MF; Romero ED; García MI; Rodríguez JA; Bellido JL
    Int J Antimicrob Agents; 2008 Dec; 32(6):541-3. PubMed ID: 18789848
    [No Abstract]   [Full Text] [Related]  

  • 6. Tigecycline Susceptibility of Klebsiella pneumoniae Complex and Escherichia coli Isolates from Companion Animals: The Prevalence of Tigecycline-Nonsusceptible K. pneumoniae Complex, Including Internationally Expanding Human Pathogenic Lineages.
    Sato T; Harada K; Usui M; Tsuyuki Y; Shiraishi T; Tamura Y; Yokota SI
    Microb Drug Resist; 2018; 24(6):860-867. PubMed ID: 29232167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
    Roy S; Datta S; Viswanathan R; Singh AK; Basu S
    J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline.
    Linkevicius M; Anderssen JM; Sandegren L; Andersson DI
    J Antimicrob Chemother; 2016 May; 71(5):1307-13. PubMed ID: 26851608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.
    Li X; Mu X; Yang Y; Hua X; Yang Q; Wang N; Du X; Ruan Z; Shen X; Yu Y
    Int J Antimicrob Agents; 2016 Apr; 47(4):324-7. PubMed ID: 26944192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
    Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004-2014.
    Marco F; Dowzicky MJ
    J Glob Antimicrob Resist; 2016 Sep; 6():50-56. PubMed ID: 27530839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model.
    Cai Y; Lim TP; Teo JQ; Sasikala S; Chan EC; Hong YJ; Lee W; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance.
    Linkevicius M; Sandegren L; Andersson DI
    Antimicrob Agents Chemother; 2016 Feb; 60(2):789-96. PubMed ID: 26596936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
    Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
    J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
    Daurel C; Fiant AL; Brémont S; Courvalin P; Leclercq R
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4953-4. PubMed ID: 19738023
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).
    Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.